Rybelsus®

Chronic Conditions

Rybelsus®

Generic For Rybelsus®

starting at $1,374.99

Rybelsus® (semaglutide) is a prescription medication approved by the FDA for managing type 2 diabetes in adults. This drug is part of a group called GLP-1 receptor agonists, which work by imitating the incretin hormone GLP-1. This helps to increase insulin release after eating, lower glucagon levels, and slow down the emptying of the stomach, all of which contribute to improved blood sugar levels. Semaglutide helps to reduce appetite by making patients feel fuller, faster.

Semaglutide, the active ingredient in Rybelsus®, is used off-label for weight loss

Dosing can be increased based on tolerance and effectiveness

Semaglutide is used to control high blood sugar with a proper diet and exercise program in people with type 2 diabetes

Controlling blood sugar helps to prevent kidney damage, blindness, nerve problems, loss of limbs and sexual function problems

Proper control of diabetes may lessen the risk of a heart attack or stroke

May take several weeks for the medication to reach its full effectiveness

3mg initial dose is intended to reduce GI symptoms, it often dose not provide effective glycemic control

Select Dosage (Must Click Below)

Select Dosage (Select After Clicking Dosage)

Quantity (Select After Clicking Dosage)

Subscription

H&P Certification

Tell us about yourself.

“You need to carefully review and make sure you can agree to each statement. If there are questions, a doctor will be in touch after checkout.”

Rybelsus®

I agree that I:

Am 18 years or older
Attest that I will be using this medication as prescribed and for my own personal use
Have not had a hypersensitivity reaction to semaglutide, Rybelsus or any component of the formulation
Have already been prescribed within the last 6 months and/or am currently taking the requested dose
Understand and am aware of the monitoring parameters for A1C levels and am completing the lab work as required
Don’t have a personal or family history of medullary thyroid carcinoma (MTC) or a history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Am aware and understand the symptoms of thyroid tumors (eg, a mass in the neck, dysphagia, dyspnea, persistent hoarseness).
Understand and am aware that Rybelsus has a boxed warning that indicates it is unknown whether semaglutide causes thyroid C-cell tumors.
Do not have type 1 diabetes or diabetic ketoacidosis
Have taken and tolerated previous dosing titration (if applicable)
Have not had bariatric surgery
Understand and am aware this medication slows gastric emptying which can alter the absorption of other medications
understand this medication has shown incidence of acute kidney injury, diabetic retinopathy, gallbladder disease, gastrointestinal side effects, and pancreatitis
Am not pregnant or breastfeeding
Do not have kidney or liver impairment
Understand psychiatric effects have occurred, such as suicidal thoughts, with other medications for weight management
Understand and am aware this product should not be swallowed and if accidental ingestion occurs, side effects may include burning in the mouth, sore tongue, abdominal pain, nausea, vomiting, and diarrhea
Understand and am aware that prolonged ingestion with excessive doses may result in dental fluorosis and/or osseous changes
Understand I can find more information regarding drug-drug interactions at https://www.drugs.com/drug_interactions.html
Understand this is not a comprehensive list of precautions, risks, side effects, or details about taking this medication
Understand that only major drug interactions are listed and have not been reviewed against the other medications, supplements, or herbal products I may be taking unless also filled by TelyRx

understand that TelyRx LLC does not provide medical care and the providers who use TelyRx to provide telehealth services (“Telehealth Providers”) should not replace your primary provider.
understand that the Telehealth Providers are not able to: (1) monitor ongoing health or lab values for side effects or efficacy, (2) observe how you (or your pet) tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended and assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Providers.
understand that by using this site, I have created a patient-client-doctor relationship and I am being directed by the Telehealth Providers to consult my primary provider soon after beginning any treatment prescribed by the Telehealth Providers.
understand that this is a supplemental mode of care for your convenience and the Telehealth Providers are not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with your primary provider.

I agree that all statements above are true and my physician visit is complete.

Cancel

Web-form is not active.

Skip to the end of the images gallery

For illustration purposes only. Product appearance may vary based on manufacturer availability.

Skip to the beginning of the images gallery

Rybelsus® (Semaglutide) Side Effects

Rybelsus (Semaglutide) side effects may include: diarrhea, constipation, nausea, hypoglycemia, dizziness, pancreatitis, abdominal pain, fast heartbeat.
Consumer Information Use and Disclaimer

This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.